Practising high-resolution anoscopy
Joel M. PalefskyUniversity of California, San Francisco, CA 94143, USA. Email: Joelp@medicine.ucsf.edu
Sexual Health 9(6) 580-586 https://doi.org/10.1071/SH12045
Submitted: 3 April 2012 Accepted: 23 July 2012 Published: 27 November 2012
Abstract
The incidence of anal cancer is increasing in the general population among both men and women. The incidence is particularly high among men who have sex with men and HIV-infected men and women. Anal cancer is similar to cervical cancer and is associated with human papillomavirus (HPV). Anal cancer is potentially preventable through primary prevention with HPV vaccination or secondary prevention. Secondary prevention is modelled after cervical cancer, where cytology is used as a screening tool to identify women who need colposcopy. Colposcopy includes magnification of the cervix, which, along with acetic acid and Lugol’s solution, is used to visualise and biopsy potentially precancerous lesions, enabling treatment before progression to cervical cancer. Anal cancer is likely preceded by high-grade anal intraepithelial neoplasia (HGAIN), and a colposcope with acetic acid and Lugol’s solution may similarly be used to visualise HGAIN to permit biopsy and treatment in an effort to prevent anal cancer. To distinguish it from cervical colposcopy, this technique is called high-resolution anoscopy (HRA). Many of the features that distinguish low-grade AIN from HGAIN are similar to those of the cervix, but HRA poses several additional challenges compared with cervical colposcopy. These include uneven topography; obscuring of lesions due to haemorrhoids, folds, stool or mucus; or lesions being located at the base of folds and anal glands. Consequently, a long learning curve is typically required before becoming fully competent in this technique. The technique of HRA, its uses and challenges in prevention of anal cancer are described in this article.
Additional keywords: anal cancer, anal intraepithelial neoplasia, colposcopy, human papillomavirus.
References
[1] Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009; 124 2375–83.| Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1MXltFaqtrk%3D&md5=134bfbdcad1e4cb8d06432e7489283e9CAS |
[2] Palefsky JM. Anal cancer prevention in HIV-positive men and women. Curr Opin Oncol 2009; 21 433–8.
| Anal cancer prevention in HIV-positive men and women.Crossref | GoogleScholarGoogle Scholar |
[3] Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58 1–207.
[4] Scholefield JH, Sonnex C, Talbot IC, Palmer JG, Whatrup C, Mindel A, et al Anal and cervical intraepithelial neoplasia: possible parallel. Lancet 1989; 334 765–9.
| Anal and cervical intraepithelial neoplasia: possible parallel.Crossref | GoogleScholarGoogle Scholar |
[5] Chin-Hong PV, Palefsky JM. Human papillomavirus anogenital disease in HIV-infected individuals. Dermatol Ther 2005; 18 67–76.
| Human papillomavirus anogenital disease in HIV-infected individuals.Crossref | GoogleScholarGoogle Scholar |
[6] Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177 361–7.
| Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1c7isF2qug%3D%3D&md5=9307401f9018341d4be05af9f95c5583CAS |
[7] Conley L, Bush T, Darragh TM, Palefsky JM, Unger ER, Patel P, et al Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States. J Infect Dis 2010; 202 1567–76.
| Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3cbhtFOmtw%3D%3D&md5=69e6ad464e4e7e29cf987589aec24e90CAS |
[8] Park IU, Palefsky JM. Evaluation and management of anal intraepithelial neoplasia in HIV-negative and HIV-positive men who have sex with men. Curr Infect Dis Rep 2010; 12 126–33.
| Evaluation and management of anal intraepithelial neoplasia in HIV-negative and HIV-positive men who have sex with men.Crossref | GoogleScholarGoogle Scholar |
[9] Palefsky JM, Holly EA, Hogeboom CJ, Jay N, Berry M, Darragh TM. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr 1997; 14 415–22.
| Anal cytology as a screening tool for anal squamous intraepithelial lesions.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2szhsVSksQ%3D%3D&md5=843dc3a3960718701c4eb9321b89291cCAS |
[10] Berry JM, Palefsky JM, Jay N, Cheng SC, Darragh TM, Chin-Hong PV. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum 2009; 52 239–47.
| Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia.Crossref | GoogleScholarGoogle Scholar |
[11] Bean SM, Chhieng DC. Anal–rectal cytology: a review. Diagn Cytopathol 2010; 38 538–46.
[12] Jay N, Holly EA, Berry M, Hogeboom CJ, Darragh TM, Palefsky JM. Colposcopic correlates of anal squamous intraepithelial lesions. Dis Colon Rectum 1997; 40 919–28.
| Colposcopic correlates of anal squamous intraepithelial lesions.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK2svhtleqsQ%3D%3D&md5=a7f196a8d95e3cf95bca0dd45df9185cCAS |
[13] Stoler MH, Vichnin MD, Ferenczy A, Ferris DG, Perez G, Paavonen J, et al The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials. Int J Cancer 2011; 128 1354–62.
| The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXhtFKrt7c%3D&md5=2a17e2de8ff771d46d182b0ad996ea94CAS |
[14] Apgar BS, Brotzman GL, Spitzer M, eds. Colposcopy principles and practice, 2nd edition. Saunders: Philadelphia; 2008.
